| 中文名称 | 3-溴丙酮酸 |
| 英文名称 | 3-Bromopyruvic acid |
| CAS号 | 1113-59-3 |
| 分子式 | C3H3BrO3 |
| 分子量 | 166.96 |
| EINECS号 | 214-206-5 |
| 熔点 | 77-82 °C |
| 沸点 | 223.4±23.0 °C(Predicted) |
| 密度 | 1.7314 (rough estimate) |
| 折射率 | 1.4650 (estimate) |
| 溶解度 | 水中的溶解度:1g/10mL,透明,无色 |
| 形态 | 白色结晶固体 |
| 酸度系数(pKa) | 1.84±0.54(Predicted) |
| 颜色 | 白色到近乎白色 |
| 水溶解性 | Soluble in water, dimethyl sulfoxide, ethyl acetate and water. |
| BRN | 1746786 |
| 危险品标志 | C |
| 危险类别码 | 34-20/21/22 |
| 安全说明 | 26-36/37/39-45-27 |
| 危险品运输编号 | UN 3261 8/PG 2 |
| WGK Germany | 3 |
| RTECS号 | UZ0840000 |
| Hazard Note | Corrosive |
| TSCA | Yes |
| 海关编码 | 29183000 |
| 危险等级 | 8 |
| 包装类别 | II |
3-Bromopyruvate enhances TRAIL-induced apoptosis in breast cancer cells.
3-Bromopyruvate (Bromopyruvic acid), a hexokinase II inhibitor, can induce apoptosis in hepatocellular carcinoma cells by inducing endoplasmic reticulum (ER) stress.
3-Bromopyruvate inhibits ATP generation and upregulates the expression of DR5. 3-Bromopyruvate upregulates CHOP, GRP78 and the phosphorylation of AMPK and augments TRAIL-induced Bax and caspase-3 levels.
Cell Viability Assay
| Cell Line: | MCF-7 and MDA-MB-231 cells |
| Concentration: | 40, 80, 160 or 320 µM |
| Incubation Time: | 24 hours |
| Result: | 3-Bromopyruvate (80 and 160 µmol/l) and TRAIL (400 ng/ml) significantly inhibited cell viability. |
3-Bromopyruvate (8 mg/kg; i.p.; every 4 days for 28 days) shows a synergistic antitumor effect in MCF-7 cell xenografts in nude mice.
| Animal Model: | Female nude mice (BALB/c; 4-5-weeks old and 18-20 g) |
| Dosage: | 8 mg/kg |
| Administration: | I.p.; every 4 days for 28 days |
| Result: | Showed antitumor efficacy in tumor xenografts. |